Skip to main content
. 2015 May 15;10(5):e0126957. doi: 10.1371/journal.pone.0126957

Fig 1. Expression of miRNA 9 in the studied groups.

Fig 1

Group II: T2D subjects, Group III: CAD subjects, Group IV: T2D subjects with CAD. Data on the figure is represented as 100% change of control value. a: Significantly different from group I at p = 0.000, b: Significantly different from group II at p = 0.000, c: Significantly different from group III at p = 0.000